지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Kidney transplantation is the treatment of choice for end stage renal disease. Successful kidney transplantation improves thequality of life and reduces the mortality risk for most patients, when compared with maintenance dialysis. Recent advances,including immunosuppressants, desensitization treatment for highly sensitized kidney transplant candidates, and better medicalcare, have resulted in an increase number of transplants with improved outcomes. However, kidney transplant recipients requireclose follow-up after transplantation since they are on complex immunosuppressive regimens that render them susceptible toinfection, malignancy, and cardiovascular disease. The additional obstacles of kidney transplantation include the lack ofimprovement in long term outcomes, shortage of organs, and multiple co-morbidities due to their underlying chronic kidneydisease. To improve the long-term outcome of renal allograft, physicians must be aware in developing newer immunosuppressiveregimens, with lower side effects, and reduction of death with functioning graft and chronic allograft dysfunction will be thegreatest challenge of all physicians who care for kidney transplant recipients. This review highlights current status of kidneytransplantation in Korea, brief transplant immunology, immunologic tests, donor/recipient evaluation, immunosuppressivemedications, and complications of kidney transplantation involving rejection, post transplantation infections, malignancy,cardiovascular disease and recurrence of primary disease.
목차
등록된 정보가 없습니다.
참고문헌 (26)
참고문헌 신청
Billing H / 2012 / IVIG and rituximab for
Chapman JR / 2011 / Chronic calcineurin inhibitor nephrotoxicitylest we forget / Am J Transplant 11 : 693 ~ 697
Cohen D / 2012 / Pros and cons for C4d as a biomarker / Kidney Int 81 : 628 ~ 639
Denton MD / 1999 / Immunosuppressive strategies in transplantation / Lancet 353 : 1083 ~ 1091
ESRD Registry Committee / 2013 / Current Renal Replacement Therapy in Korea / Proceedings of the 33rd Annual Autumn Meeting of the Korean Society of Nephrology : 7 ~ 35
Chapman JR / 2011 / Chronic calcineurin inhibitor nephrotoxicitylest we forget / Am J Transplant 11 : 693 ~ 697
Cohen D / 2012 / Pros and cons for C4d as a biomarker / Kidney Int 81 : 628 ~ 639
Denton MD / 1999 / Immunosuppressive strategies in transplantation / Lancet 353 : 1083 ~ 1091
ESRD Registry Committee / 2013 / Current Renal Replacement Therapy in Korea / Proceedings of the 33rd Annual Autumn Meeting of the Korean Society of Nephrology : 7 ~ 35
이 논문의 저자 정보
최근 본 자료
댓글(0)
0